Business Description
Theralink Technologies Inc
NAICS : 621511
SIC : 8071
ISIN : US68235A1016
Description
Theralink Technologies Inc is a proteomics-based, precision medicine and molecular profiling company that specializes in patented Reverse Phase Protein Array (RPPA) and protein biomarker assay services that target multiple areas of oncology. The company provides precision oncology data through its Theralink Reverse Phase Protein Array (RPPA) assays to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders and non-responders to both FDA-approved and investigational drug treatments. The firm is currently generating revenue with its multiple biopharma contracts and by testing breast cancer patients with its patented Theralink assay.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | -32.02 | |||||
| Debt-to-Equity | -0.42 | |||||
| Debt-to-EBITDA | 3.76 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -115.54 | |||||
| Beneish M-Score | -61.4 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 61.8 | |||||
| 3-Year EPS without NRI Growth Rate | 47.4 | |||||
| 3-Year FCF Growth Rate | 72.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | -85.71 | |||||
| 12-1 Month Momentum % | -94.44 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Days Sales Outstanding | 20 | |||||
| Days Payable | 2207.71 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.3 | |||||
| Shareholder Yield % | -2089.4 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 73.39 | |||||
| Operating Margin % | -1214.49 | |||||
| Net Margin % | -2125.67 | |||||
| FCF Margin % | -781.42 | |||||
| ROA % | -569.34 | |||||
| ROIC % | -16.15 | |||||
| ROC (Joel Greenblatt) % | 372.94 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | 3.98 | |||||
| EV-to-EBITDA | 3.85 | |||||
| EV-to-Revenue | 38.34 | |||||
| EV-to-FCF | -4.91 | |||||
| Earnings Yield (Greenblatt) % | 25.13 | |||||
| FCF Yield % | -806.83 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:THER
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Theralink Technologies Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.635 | ||
| EPS (TTM) ($) | -0.004 | ||
| Beta | 1.52 | ||
| Volatility % | 99.37 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0.000007 | ||
| 20-Day SMA ($) | 0.0001 | ||
| 12-1 Month Momentum % | -94.44 | ||
| 52-Week Range ($) | 0.0001 - 0.0023 | ||
| Shares Outstanding (Mil) | 6,151.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Theralink Technologies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Theralink Technologies Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Theralink Technologies Inc Frequently Asked Questions
What is Theralink Technologies Inc(THER)'s stock price today?
The current price of THER is $0.00. The 52 week high of THER is $0.00 and 52 week low is $0.00.
When is next earnings date of Theralink Technologies Inc(THER)?
The next earnings date of Theralink Technologies Inc(THER) is 2025-02-20 Est..
Does Theralink Technologies Inc(THER) pay dividends? If so, how much?
Theralink Technologies Inc(THER) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers